InvestorsHub Logo
Followers 69
Posts 7941
Boards Moderated 0
Alias Born 01/29/2015

Re: tcm55 post# 11832

Friday, 10/16/2020 2:54:52 PM

Friday, October 16, 2020 2:54:52 PM

Post# of 16707
I agree with your last sentence. I wish you did as well.

However, since once AGAIN you wanna drag that crap there here, I'll give you what you asked for and I'm done with it.

So here's a reply to one of your litany of back and forth posts there today:

I don't think you understand that the trial is for patients in ICU with respiratory failure on Oxygen. This isn't like Regeneron or Algernon studying people just coming down with Covid. Most other Covid drugs are able to rapidly enroll patients. Not the same here. And to show efficacy for these types of patients will take significantly less patients. For people coming down with Covid it will take huge numbers because most get better on their own anyway.



You have thus far not responded to that particular reply. I'm not suggesting you do. It's probably better you leave well enough alone. However, for your own personal knowledge of what you own here, you should review the "Score of 4 or 5 on the WHO Ordinal Clinical Scale."

That is the Inclusion Criteria for patients enrolled in Algernon's COVID-19 clinical trial.

Algernon COVID-19 clinical trial

Must be hospitalized and requiring supplemental oxygen, or on non-invasive ventilation or high flow oxygen devices (Score of 4 or 5 on WHO Ordinal Clinical Scale)


I have nothing further to add.

Just facts.

Peace,

/////AMG

EQ Silver Arrow